|
12 September, 2024
|
ICON Survey Highlights Scale of Focus on Precision Therapies in Increasingly Complex Oncology Landscape
|
|
|
03 September, 2024
|
ICON plc to Present at the Baird 2024 Global Healthcare Conference
|
|
|
14 August, 2024
|
ICON Announces Appointment of New Chief Financial Officer
|
|
|
24 July, 2024
|
ICON Reports Second Quarter 2024 Results
|
|
|
24 July, 2024
|
ICON announces results of Annual General Meeting and changes to the Board of Directors
|
|
|
10 July, 2024
|
ICON Recognised for Leadership Position in Clinical Research Industry and as Socially Responsible Employer
|
|
|
01 July, 2024
|
ICON plc Schedules Second Quarter 2024 Earnings Conference Call
|
|
|
04 June, 2024
|
ICON plc to Present at the Jefferies Global Healthcare Conference
|
|
|
30 May, 2024
|
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance
|
|
|
20 May, 2024
|
ICON plc to hold Investor Day Meeting on May 30, 2024
|
|
|
09 May, 2024
|
ICON releases its ICON Cares 2023 Report
|
|
|
30 April, 2024
|
ICON Announces Pricing of USD 2 Billion Notes
|
|
|
24 April, 2024
|
ICON Reports First Quarter 2024 Results
|
|
|
03 April, 2024
|
ICON Announces CFO Transition
|
|
|
25 March, 2024
|
ICON plc Schedules First Quarter 2024 Earnings Conference Call
|
|
|
26 February, 2024
|
ICON plc to Present at Upcoming Investor Conferences
|
|
|
21 February, 2024
|
ICON Reports Fourth Quarter and Full Year 2023 Results
|
|
|
30 January, 2024
|
ICON plc Schedules Fourth Quarter and Full Year 2023 Earnings Conference Call
|
|
|
24 January, 2024
|
New ICON Survey Highlights Importance of Combination Therapies in Future Obesity Treatment
|
|
|
09 January, 2024
|
ICON Issues Financial Guidance for Full Year 2024
|
|
